FAK/SRC INHIBITION ALLEVIATES THE PERSISTENT FIBROTIC PHENOTYPE OF LESIONAL SCLERODERMA FIBROBLASTS

Shiwen Xu(Northeast Agricultural University), Dietmar Abraham(Medical University of Vienna), Katherine Thompson, CP Denton(The Royal Free Hospital), A Leask
UCL Discovery (University College London)
February 1, 2012
Cited by 0

Related Papers

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Raf-1-associated Protein Phosphatase 2A as a Positive Regulator of Kinase Activation
|Journal of Biological Chemistry|2000|219
Endothelin-1 Induces Expression of Matrix-associated Genes in Lung Fibroblasts through MEK/ERK
|Journal of Biological Chemistry|2004|170
The antagonistic effect of selenium on lead-induced apoptosis via mitochondrial dynamics pathway in the chicken kidney
|Chemosphere|2017|159